In this article, we are going to analyze the report about the Asia-Pacific market among the global leaders of quality, which manufacturers human growth hormone (HGH) in 2025. It is used in cases of growth hormone deficiency and Turner syndrome in the human body.
The Indian manufacturer AllChem Asia and its product of growth hormon, Somatin, was ranked among the top 10 growth hormones for its quality and purity, taking the 6th place in the Asia-Pacific region!
Obviously, the projections are based on estimates obtained with the help of using healthcare analytics tools and final levels of evidence from clinical trials predicated on the following criteria:
– increased levels of IGF-1 in the blood;
– growth retardation of the children with growth hormone deficiency;
– changes in body proportions;
In fact, AllChem Asia Somatin demonstrates strong results and accelerated sales progress in the 2023-2025 period.
- Growth hormone sales share in the Asia-Pacific region:
- Danish pharmaceutical company Novo Nordisk – Norditropin 25%
- German pharmaceutical company Pfizer – Genotropin 21-22%
- US company Eli Lilly – Humatrope 14-15%
- German company Merck – Saizen 10-11%
- Swiss pharmaceutical company Sandoz – Novartis 10-13%
- Indian marketing company AllChem Asia – Somatin 8-9%
- Swiss company Ferring Pharmaceuticals – Zomacton >5%
- Chinese pharmaceutical company ShanghaiRAAS – Somatropin <10%
- Other regional/international manufacturers 5 to 10%
The Asia-Pacific region is getting the fastest progress at 14.05% CAGR
Despite the infrastructure gaps, India shows significant growth since private insurance is expanding and diagnostics are improving.
Also, investments in local production by various firms are aimed at reducing delivery times and isolating the human growth hormone market from the global shortage.
Altogether, our report defines the human growth hormone (HGH) market as all prescription recombinant somatropin products, daily and extended release, which are being sold in regulated channels for FDA- or EMA-approved clinical indications, such as growth hormone deficiency of children and adults, Turner syndrome, Prader-Willi syndrome, and few cases for gestational age.
